|
Mar 19
|
AstraZeneca (AZN) Follows Boehringer, to Cap Inhaler Cost in US
|
|
Mar 19
|
Fusion Pharmaceuticals Stock Soars. It’s Being Acquired by AstraZeneca in $2.4 Billion Deal.
|
|
Mar 19
|
Super Micro, XPeng, AstraZeneca: Trending tickers
|
|
Mar 19
|
Heard on the Street: Pharma Goes Radioactive as AstraZeneca Announces Fusion Deal
|
|
Mar 19
|
AstraZeneca buys Canadian cancer treatment firm for close to £2bn
|
|
Mar 19
|
AstraZeneca to acquire Fusion to accelerate the development of next-generation radioconjugates to treat cancer
|
|
Mar 19
|
AstraZeneca snaps up rival to develop pioneering new cancer treatment
|
|
Mar 19
|
Trending tickers: Nvidia, Apple, Unilever and Astrazeneca
|
|
Mar 19
|
AstraZeneca joins radiopharmaceutical deals spree with $2.4B buyout of Fusion
|
|
Mar 19
|
AstraZeneca Buys Fusion for Initial $2 Bln
|
|
Mar 19
|
AstraZeneca bets on next-generation cancer therapy with $2 billion Fusion deal
|
|
Mar 18
|
Now That Two Inhaler Makers Are Capping Patient Costs, Will More Follow?
|
|
Mar 18
|
AstraZeneca to cap out-of-pocket inhaler costs in US, following rival Boehringer's move
|
|
Mar 18
|
AstraZeneca caps patient out-of-pocket costs at $35 per month for its US inhaled respiratory portfolio
|
|
Mar 17
|
30 Biggest Biotechnology Companies in the World
|
|
Mar 15
|
Pharma Stock Roundup: AZN's New Acquisition, FDA Updates for NVO & LLY and More
|
|
Mar 14
|
20 Countries That Spend the Most on Healthcare
|
|
Mar 14
|
AstraZeneca (AZN) to Acquire Amolyt Pharma for $1.05 Billion
|
|
Mar 14
|
12 Most Profitable Biotech Stocks To Invest In
|
|
Mar 14
|
AstraZeneca adds another rare disease drug in $800M buyout of startup Amolyt
|